Mainstay raised a total of approximately €30 million from the Ireland Strategic Investment Fund, existing investors and new investors.
Mainstay is a medical device company focused on bringing to market an innovative implantable neurostimulation system, ReActiv8, for people with disabling Chronic Low Back Pain. The Company is headquartered in Dublin, Ireland. It has subsidiaries operating in Ireland, the United States, Australia, Germany and the Netherlands, and is listed on the regulated market of the Euronext Paris and the ESM of the Irish Stock Exchange.
The Matheson team was led by George Brady with support from a team of specialists in other areas across the firm.